US Edition
Published • loading... • Updated
Alnylam Pharmaceuticals (NASDAQ:ALNY) EVP Sells $607,446.72 in Stock
Summary
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Alnylam Pharmaceuticals (NASDAQ:ALNY) CEO Yvonne Greenstreet Sells 6,958 Shares
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) CEO Yvonne Greenstreet sold 6,958 shares of the stock in a transaction on Friday, February 13th. The shares were sold at an average price of $310.08, for a total value of $2,157,536.64. Following the completion of the sale, the chief executive officer directly owned 85,662 shares of […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
